Dr. Christine McMahon, MD
Claim this profileUniversity of Colorado Denver I Anschutz Medical Campus
Area of expertise
Acute Myeloid Leukemia
Christine McMahon, MD has run 4 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Relapse
Christine McMahon, MD has run 1 trial for Relapse. Some of their research focus areas include:
Affiliated Hospitals
University Of Colorado Denver I Anschutz Medical Campus
UC Health Blood Disorders And Cell Therapies Center - Anschutz Medical Campus
Clinical Trials Christine McMahon, MD is currently running
Ziftomenib Combinations
for Acute Myeloid Leukemia
Ziftomenib is an investigational drug in development for the treatment of patients with acute myeloid leukemia (AML) with certain genetic alterations. This protocol has 3 separate arms that will investigate the benefits and risks of adding ziftomenib to standard-of-care (SOC) drug treatments in patients who have AML with certain genetic mutations. Both newly diagnosed and relapsed refractory patients with AML will be assigned to different cohorts based on specific study criteria and physician discretion. The purpose of this study is to assess the safety, tolerability, and early signs of efficacy of ziftomenib in combination with SOC drugs to treat AML.
Recruiting
1 award
Phase 1
Venetoclax + Cladribine
for Acute Myeloid Leukemia
This trial uses Cladribine and Venetoclax to treat a specific type of leukemia that hasn't responded to other treatments. Cladribine has been used effectively in treating various blood cancers, including hairy cell leukemia. It targets patients with a type of leukemia who didn't improve with previous therapies. The treatment works by stopping cancer cells from growing and making them easier to kill.
Recruiting
1 award
Phase 2
More about Christine McMahon, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Christine McMahon, MD has experience with
- Azacitidine
- Venetoclax
- Cladribine
- Primary Palliative Care
- Specialty Palliative Care
- Cytarabine
Breakdown of trials Christine McMahon, MD has run
Acute Myeloid Leukemia
Adult Acute Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christine McMahon, MD specialize in?
Christine McMahon, MD focuses on Acute Myeloid Leukemia and Relapse. In particular, much of their work with Acute Myeloid Leukemia has involved KRAS positive patients, or patients who are NRAS positive.
Is Christine McMahon, MD currently recruiting for clinical trials?
Yes, Christine McMahon, MD is currently recruiting for 3 clinical trials in Denver Colorado. If you're interested in participating, you should apply.
Are there any treatments that Christine McMahon, MD has studied deeply?
Yes, Christine McMahon, MD has studied treatments such as Azacitidine, Venetoclax, Cladribine.
What is the best way to schedule an appointment with Christine McMahon, MD?
Apply for one of the trials that Christine McMahon, MD is conducting.
What is the office address of Christine McMahon, MD?
The office of Christine McMahon, MD is located at: University of Colorado Denver I Anschutz Medical Campus, Denver, Colorado 80204 United States. This is the address for their practice at the University of Colorado Denver I Anschutz Medical Campus.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.